Invention Grant
- Patent Title: Nucleic acids encoding anti-OX40L antibodies
-
Application No.: US17115021Application Date: 2020-12-08
-
Publication No.: US11753479B2Publication Date: 2023-09-12
- Inventor: Jamie Campbell , Steve Holmes , Ian Kirby , Miha Kosmac
- Applicant: Kymab Limited
- Applicant Address: GB Cambridge
- Assignee: KYMAB LIMITED
- Current Assignee: KYMAB LIMITED
- Current Assignee Address: GB Cambridge
- Agency: LATHROP GPM LLP
- Agent James H. Velema; Judith L. Stone-Hulslander
- Priority: GB 03775 2014.03.04
- The original application number of the division: US16188541 2018.11.13
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; C07K16/24 ; A61K39/00
Abstract:
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Public/Granted literature
- US20210087287A1 ANTIBODIES, USES & METHODS Public/Granted day:2021-03-25
Information query
